MorphoSys AG (MOR)
NASDAQ: MOR · IEX Real-Time Price · USD
18.10
-0.06 (-0.33%)
At close: Jul 2, 2024, 4:00 PM
18.04
-0.06 (-0.33%)
After-hours: Jul 2, 2024, 5:14 PM EDT
MorphoSys AG Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for MorphoSys AG stock have an average target of 12.13, with a low estimate of 4.75 and a high estimate of 18.25. The average target predicts a decrease of -32.98% from the current stock price of 18.10.
Analyst Consensus: Hold
* Price targets were last updated on Mar 14, 2024.
Analyst Ratings
The average analyst rating for MorphoSys AG stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $17 → $18 | Buy → Hold | Downgrades | $17 → $18 | +0.83% | Mar 14, 2024 |
| Wells Fargo | Wells Fargo | Buy Reiterates $17 | Buy | Reiterates | $17 | -6.08% | Feb 5, 2024 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 19, 2024 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 16, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $10 → $17 | Buy | Maintains | $10 → $17 | -6.08% | Dec 15, 2023 |
Financial Forecast
Revenue This Year
247.27M
from 238.28M
Increased by 3.77%
Revenue Next Year
308.52M
from 247.27M
Increased by 24.77%
EPS This Year
-4.76
from -1.38
EPS Next Year
-3.62
from -4.76
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 303.5M | 387.5M | 529.8M | 920.0M | 1.1B |
| Avg | 247.3M | 308.5M | 449.1M | 730.2M | 1.0B |
| Low | 120.1M | 150.4M | 380.6M | 558.4M | 996.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 27.4% | 56.7% | 71.7% | 104.9% | 46.3% |
| Avg | 3.8% | 24.8% | 45.6% | 62.6% | 40.6% |
| Low | -49.6% | -39.2% | 23.4% | 24.3% | 36.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -1.72 | -0.37 | 2.97 | -1.54 |
| Avg | -4.76 | -3.62 | -1.19 | -1.49 |
| Low | -9.94 | -6.57 | -4.57 | -1.44 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | - |
| Avg | - | - | - | - |
| Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.